Dana dhuwit perusahaan altimmune.com (ALT)

ALT (Altimmune) - tandha merek perusahaan

The cash asset volume metric on GURU.Markets tracks capital dynamics, and the current value is 0.26. Stable demand for anti-obesity treatments supports the liquidity of Altimmune, Inc. (ALT), despite geopolitical supply chain risks. The development of metabolic drugs remains independent of economic conditions, relying instead on research cycles. Meanwhile, Altimmune, Inc. (ALT) minimizes production risks by maintaining raw material inventories with external contractors.

Altimmune Inc - Gunggung dana dhuwit perusahaan ALT (periode 04.07.2022 - 21.11.2026)

Rincian metrik lan analitis perusahaan Altimmune Inc (ALT)

Analisis fundamental perusahaan:Altimmune Pharma ALT
Produk mawa merek Altimmune

Operational efficiency directly determines the rate of burn and replenishment of liquid assets. This indicator captures the actual cash balance at the close of trading sessions, reflecting the issuer's current financial stability. For Altimmune, Inc. (ALT), this resource is critical for protecting patent potential and refining the drug Pemvidutide. The trend in cash holdings allows for an assessment of the company's margin of safety while scaling its technological advantage.

Analisis perusahaan pesaing

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Soleno Therapeutics Inc SLNO|Dhuwit awis perusahaan FOLD (Amicus Therapeutics Inc)|ETNB (89bio Corp) - Sisa dhuwit perusahaan|Agios Pharmaceuticals - Dhuwit awis perusahaan|Gunggung dana dhuwit perusahaan GPCR (Structure Therapeutics Inc.)|MDXG: Dhuwit awis perusahaan|Rezolute - Gunggung dana dhuwit perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis perusahaan|Dhuwit awis perusahaan MBX Bio|Dhuwit awis perusahaan AARD|Dana dhuwit perusahaan SGMT|Volume dana dhuwit perusahaan BIOA|Aset likuid perusahaan Biomea Fusion|Dana dhuwit perusahaan Quince Therapeutics QNCX|Volume dana dhuwit perusahaan Fractyl Health, Inc GUTS|VTVT: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Agape ATP|PLUR (Pluri) - Dhuwit awis perusahaan|SYBX - Aset likuid perusahaan|Dana dhuwit perusahaan Lipocine Corp|Volume dana dhuwit perusahaan matinasbiopharma.com|Dana dhuwit perusahaan Spruce Biosciences, Inc. (SPRB)|Gunggung dana dhuwit perusahaan GLTO|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)